BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9788492)

  • 1. Japanese mass screening for neuroblastoma.
    Kudo K; Arai Y; Kondo Y
    Lancet; 1998 Oct; 352(9136):1316. PubMed ID: 9788492
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for neuroblastoma: a resurrected idea?
    Maris JM; Woods WG
    Lancet; 2008 Apr; 371(9619):1142-3. PubMed ID: 18395561
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroblastoma screening test may do more harm than good.
    Law C
    J Natl Cancer Inst; 1997 Feb; 89(4):276-7. PubMed ID: 9064371
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological analysis of neuroblastoma in mass screened negative cases.
    Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
    Prog Clin Biol Res; 1991; 366():603-8. PubMed ID: 2068179
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
    Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History and current status of neuroblastoma screening in Japan.
    Takeda T
    Med Pediatr Oncol; 1989; 17(5):361-3. PubMed ID: 2796850
    [No Abstract]   [Full Text] [Related]  

  • 8. Mass screening for neuroblastoma in Japan. Committee of the Neuroblastoma Mass Screening Study of the Japanese Society of Pediatric Oncology.
    Sawada T; Nagahara N; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Okawa H; Tsunoda A; Sakurai M
    Acta Paediatr Jpn; 1990 Dec; 32(6):725-33. PubMed ID: 2082676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is neuroblastoma screening evaluation needed and feasible?
    Estève J; Parker L; Roy P; Herrmann F; Duffy S; Frappaz D; Lasset C; Hill C; Sancho-Garnier H; Michaelis J
    Br J Cancer; 1995 Jun; 71(6):1125-31. PubMed ID: 7779698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
    Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
    Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of mass screening on age-specific incidence of neuroblastoma.
    Bessho F
    Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
    Schilling FH; Oberrauch W; Schanz F; Treuner J
    Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
    Woods WG; Tuchman M; Lemieux B
    Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
    [No Abstract]   [Full Text] [Related]  

  • 14. Past and future of neuroblastoma screening in Japan.
    Sawada T
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cases of neuroblastoma missed by the mass screening programs.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J; Kawai T
    Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening babies for neuroblastoma.
    Bell S
    Health Visit; 1991 Feb; 64(2):47-9. PubMed ID: 2001968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where should neuroblastoma mass screening go?
    Bessho F
    Lancet; 1996 Dec 21-28; 348(9043):1672. PubMed ID: 8973422
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for neuroblastoma: progress and pitfalls.
    Ross JA; Davies SM
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):189-94. PubMed ID: 10067819
    [No Abstract]   [Full Text] [Related]  

  • 20. Poor prognosis neuroblastoma: is screening the answer?
    Craft AW; Parker L
    Br J Cancer Suppl; 1992 Aug; 18():S96-101. PubMed ID: 1503935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.